Kurs Kun Run Biotechnology, Inc.

Aktien

17.06.10	KUN RUN BIOTCH : Kun Run Biotechnology Announces That They Have Obtained the Manufacturing Approval for Entecavir from the China State Food and Drug Administration
22.04.10	KUN RUN BIOTCH : Kun Run Biotechnology, Inc. Executes Purchase Agreements for Approximately $8 Million Private Placement
30.03.10	KUN RUN BIOTCH : Kun Run Biotechnology Reports Fourth Quarter and Fiscal Year 2009 Financial Results
13.11.09	KUN RUN BIOTCH : Kun Run Biotechnology, Inc. Announces Third Quarter 2009 Results
30.11.-1	KUN RUN BIOTECHNLG : Kun Run Biotechnology, Inc. Year-End Revenues Increase 56% to $11.6 million

Zu einer Liste hinzufügen 0 ausgewählt Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein Einloggen Anmeldung	%	% 5 Tage	% 1 Jahr	Veränd. 3 Jahre	Kap.($)
KUN RUN BIOTECHNOLOGY, INC.	-.--%	-.--%	-	-	0
SUN PHARMACEUTICAL INDUSTRIES LTD.	-0.08%	-1.43%	+15.87%	+69.30%	47.71 Mrd.
OTSUKA HOLDINGS CO., LTD.	+0.08%	+1.58%	+52.18%	+123.09%	40.3 Mrd.
CIPLA LIMITED	-0.40%	-1.23%	-10.08%	+16.38%	12.09 Mrd.
ZYDUS LIFESCIENCES LIMITED	+1.11%	-1.34%	+13.27%	+73.55%	11.68 Mrd.
KRKA, D. D.	+0.19%	+0.58%	+30.98%	+158.71%	9.19 Mrd.
GEDEON RICHTER	-0.39%	-0.92%	+20.49%	+38.72%	7.57 Mrd.
ONO PHARMACEUTICAL CO., LTD.	-0.29%	+1.35%	+46.56%	-11.75%	7.24 Mrd.
GLENMARK PHARMACEUTICALS LIMITED	-0.64%	-0.02%	+19.65%	+205.65%	6.84 Mrd.
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-5.36%	-6.36%	-38.04%	+22.49%	5.42 Mrd.
Durchschnitt	-0.58%	-1.11%	+16.76%	+77.35%	16.45 Mrd.
Gewichteter Durchschnitt nach Marktkapitalisierung	-0.20%	-0.57%	+24.31%	+84.56%